U.S. flag

An official website of the United States government

NM_001243279.3(ACSF3):c.1608G>A (p.Trp536Ter) AND Combined malonic and methylmalonic acidemia

Germline classification:
Pathogenic/Likely pathogenic (5 submissions)
Last evaluated:
Mar 14, 2024
Review status:
2 stars out of maximum of 4 stars
criteria provided, multiple submitters, no conflicts
Somatic classification
of clinical impact:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Somatic classification
of oncogenicity:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Record status:
current
Accession:
RCV001062791.15

Allele description [Variation Report for NM_001243279.3(ACSF3):c.1608G>A (p.Trp536Ter)]

NM_001243279.3(ACSF3):c.1608G>A (p.Trp536Ter)

Gene:
ACSF3:acyl-CoA synthetase family member 3 [Gene - OMIM - HGNC]
Variant type:
single nucleotide variant
Cytogenetic location:
16q24.3
Genomic location:
Preferred name:
NM_001243279.3(ACSF3):c.1608G>A (p.Trp536Ter)
HGVS:
  • NC_000016.10:g.89146044G>A
  • NG_031961.1:g.57236G>A
  • NM_001127214.4:c.1608G>A
  • NM_001243279.3:c.1608G>AMANE SELECT
  • NM_001284316.2:c.813G>A
  • NM_174917.5:c.1608G>A
  • NP_001120686.1:p.Trp536Ter
  • NP_001230208.1:p.Trp536Ter
  • NP_001271245.1:p.Trp271Ter
  • NP_777577.2:p.Trp536Ter
  • NC_000016.9:g.89212452G>A
  • NM_001127214.4:c.1608G>A
  • NM_174917.3:c.1608G>A
  • NM_174917.4:c.1608G>A
  • NR_045667.2:n.734G>A
  • NR_104293.2:n.1999G>A
  • NR_147928.2:n.2043G>A
  • NR_147929.2:n.1797G>A
Protein change:
W271*
Links:
dbSNP: rs201954387
NCBI 1000 Genomes Browser:
rs201954387
Molecular consequence:
  • NR_045667.2:n.734G>A - non-coding transcript variant - [Sequence Ontology: SO:0001619]
  • NR_104293.2:n.1999G>A - non-coding transcript variant - [Sequence Ontology: SO:0001619]
  • NR_147928.2:n.2043G>A - non-coding transcript variant - [Sequence Ontology: SO:0001619]
  • NR_147929.2:n.1797G>A - non-coding transcript variant - [Sequence Ontology: SO:0001619]
  • NM_001127214.4:c.1608G>A - nonsense - [Sequence Ontology: SO:0001587]
  • NM_001243279.3:c.1608G>A - nonsense - [Sequence Ontology: SO:0001587]
  • NM_001284316.2:c.813G>A - nonsense - [Sequence Ontology: SO:0001587]
  • NM_174917.5:c.1608G>A - nonsense - [Sequence Ontology: SO:0001587]

Condition(s)

Name:
Combined malonic and methylmalonic acidemia
Synonyms:
Combined malonic and methylmalonic aciduria
Identifiers:
MONDO: MONDO:0013661; MedGen: C3280314; Orphanet: 289504; OMIM: 614265

Recent activity

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...

Assertion and evidence details

Submission AccessionSubmitterReview Status
(Assertion method)
Clinical Significance
(Last evaluated)
OriginMethodCitations
SCV001227614Labcorp Genetics (formerly Invitae), Labcorp
criteria provided, single submitter

(Invitae Variant Classification Sherloc (09022015))
Pathogenic
(Jan 21, 2024)
germlineclinical testing

PubMed (3)
[See all records that cite these PMIDs]

SCV002021282Revvity Omics, Revvity
criteria provided, single submitter

(ACMG Guidelines, 2015)
Likely pathogenic
(Oct 22, 2021)
germlineclinical testing

PubMed (1)
[See all records that cite this PMID]

SCV002092438Natera, Inc.
no assertion criteria provided
Likely pathogenic
(Oct 20, 2020)
germlineclinical testing

SCV002810426Fulgent Genetics, Fulgent Genetics
criteria provided, single submitter

(ACMG Guidelines, 2015)
Likely pathogenic
(Jul 22, 2021)
unknownclinical testing

PubMed (1)
[See all records that cite this PMID]

SCV004213862Baylor Genetics
criteria provided, single submitter

(ACMG Guidelines, 2015)
Likely pathogenic
(Mar 14, 2024)
unknownclinical testing

PubMed (1)
[See all records that cite this PMID]

Summary from all submissions

EthnicityOriginAffectedIndividualsFamiliesChromosomes testedNumber TestedFamily historyMethod
not providedgermlineunknownnot providednot providednot providednot providednot providedclinical testing
not providedunknownunknownnot providednot providednot providednot providednot providedclinical testing

Citations

PubMed

Exome sequencing identifies ACSF3 as a cause of combined malonic and methylmalonic aciduria.

Sloan JL, Johnston JJ, Manoli I, Chandler RJ, Krause C, Carrillo-Carrasco N, Chandrasekaran SD, Sysol JR, O'Brien K, Hauser NS, Sapp JC, Dorward HM, Huizing M; NIH Intramural Sequencing Center Group, Barshop BA, Berry SA, James PM, Champaigne NL, de Lonlay P, Valayannopoulos V, Geschwind MD, Gavrilov DK, et al.

Nat Genet. 2011 Aug 14;43(9):883-6. doi: 10.1038/ng.908.

PubMed [citation]
PMID:
21841779
PMCID:
PMC3163731

Added value of next generation gene panel analysis for patients with elevated methylmalonic acid and no clinical diagnosis following functional studies of vitamin B12 metabolism.

Pupavac M, Tian X, Chu J, Wang G, Feng Y, Chen S, Fenter R, Zhang VW, Wang J, Watkins D, Wong LJ, Rosenblatt DS.

Mol Genet Metab. 2016 Mar;117(3):363-8. doi: 10.1016/j.ymgme.2016.01.008. Epub 2016 Jan 23.

PubMed [citation]
PMID:
26827111
See all PubMed Citations (4)

Details of each submission

From Labcorp Genetics (formerly Invitae), Labcorp, SCV001227614.5

#EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
1not providednot providednot providednot providedclinical testing PubMed (3)

Description

This sequence change creates a premature translational stop signal (p.Trp536*) in the ACSF3 gene. While this is not anticipated to result in nonsense mediated decay, it is expected to disrupt the last 41 amino acid(s) of the ACSF3 protein. This variant is present in population databases (rs201954387, gnomAD 0.1%). This variant has not been reported in the literature in individuals affected with ACSF3-related conditions. ClinVar contains an entry for this variant (Variation ID: 379920). This variant disrupts a region of the ACSF3 protein in which other variant(s) (p.Arg558Trp) have been determined to be pathogenic (PMID: 21841779, 26827111). This suggests that this is a clinically significant region of the protein, and that variants that disrupt it are likely to be disease-causing. For these reasons, this variant has been classified as Pathogenic.

#SampleMethodObservation
OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
1germlineunknownnot providednot providednot providednot providednot providednot providednot provided

From Revvity Omics, Revvity, SCV002021282.3

#EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
1not providednot providednot providednot providedclinical testing PubMed (1)
#SampleMethodObservation
OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
1germlineunknownnot providednot providednot providednot providednot providednot providednot provided

From Natera, Inc., SCV002092438.1

#EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
1not providednot providednot providednot providedclinical testingnot provided
#SampleMethodObservation
OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
1germlineunknownnot providednot providednot providednot providednot providednot providednot provided

From Fulgent Genetics, Fulgent Genetics, SCV002810426.1

#EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
1not providednot providednot providednot providedclinical testing PubMed (1)
#SampleMethodObservation
OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
1unknownunknownnot providednot providednot providednot providednot providednot providednot provided

From Baylor Genetics, SCV004213862.2

#EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
1not providednot providednot providednot providedclinical testing PubMed (1)
#SampleMethodObservation
OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
1unknownunknownnot providednot providednot providednot providednot providednot providednot provided

Last Updated: Sep 29, 2024